Korean J Intern Med.  2015 Jul;30(4):550-553. 10.3904/kjim.2015.30.4.550.

Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection

Affiliations
  • 1Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea. yhimhy@jbnu.ac.kr
  • 2Research Institute of Clinical Medicine, Chonbuk National University Hospital, Jeonju, Korea.
  • 3Department of Nursing, Wonkwang University School of Medicine, Iksan, Korea.

Abstract

No abstract available.

Keyword

Lung diseases, interstitial; Imatinib mesylate; Tuberculosis

MeSH Terms

Adult
Antineoplastic Agents/*adverse effects
Antitubercular Agents/therapeutic use
Biopsy
Female
Gastrointestinal Stromal Tumors/*drug therapy/pathology/surgery
Humans
Imatinib Mesylate/*adverse effects
Lung Diseases, Interstitial/*chemically induced/diagnosis
Mycobacterium tuberculosis/*isolation & purification
Protein Kinase Inhibitors/*adverse effects
Rectal Neoplasms/*drug therapy/pathology/surgery
Tomography, X-Ray Computed
Tuberculosis, Pulmonary/diagnosis/drug therapy/*microbiology
Antineoplastic Agents
Antitubercular Agents
Imatinib Mesylate
Protein Kinase Inhibitors
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr